EGFR and non-small cell lung carcinoma: For example, amivantamab binds to both epidermal growth factor receptor (EGFR) and c-Met on NSCLC cell membrane and blocks the cell proliferation signal, which is provided by their ligands EGF and hepatocyte growth factor (HGF) [25].